Moraxella catarrhalis: A review of an important human mucosal pathogen

Microbes and Infection

Volumn 2, Issue 5, 2000, Pages 547-559

  Karalus, Richard ^a,b   Campagnari, Anthony ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Gram negative bacteria; Moraxella; Mucosal pathogen

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; BACTERIUM LIPOPOLYSACCHARIDE; BINDING PROTEIN; IRON REGULATORY FACTOR; LACTOFERRIN; OLIGOSACCHARIDE; OUTER MEMBRANE PROTEIN; TRANSFERRIN; VIRULENCE FACTOR;

BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; MORAXELLA CATARRHALIS; MYRINGOTOMY; NOMENCLATURE; NONHUMAN; OTITIS MEDIA; PRIORITY JOURNAL; REVIEW;

BACTERIA (MICROORGANISMS); MORAXELLA CATARRHALIS; NEGIBACTERIA;

EID: 0034078296     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00314-2     Document Type: Review

References (143)

1. Berk S.L. From Micrococcus to Moraxella. The reemergence of Branhamella catarrhalis. Arch. Intern. M. 150:1990;2254-2257.
2. Catlin B.W. Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin. Microbiol. Rev. 3:1990;293-320.
3. Del Beccaro M.A., Mendelman P.M., Inglis A.F., Richardson M.A., Duncan N.O., Clausen C.R., Stull T.L. Bacteriology of acute otitis media: a new perspective. J. Pediatr. 120:1992;81-84.
4. Boyle F.M., Georghiou P.R., Tilse M.H., McCormack J.G. Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections. Med. J. Aust. 154:1991;592-596.
5. Klein J.O. Current issues in upper respiratory tract infections in infants and children: rationale for antibacterial therapy. Pediatr. Infect. Dis. J. 13:1994;5-9.
6. Murphy T.F. Lung infections. 2Branhamella catarrhalisepidemiological and clinical aspects of a human respiratory tract pathogen. Thorax. 53:1998;124-128.
7. Berner R., Schumacher R.F., Brandis M., Forster J. Colonization and infection with Moraxella catarrhalis in childhood. Eur. J. Clin. Microbiol. Infect. Dis. 15:1996;506-509.
8. Bluestone C.D. Otitis media and sinusitis in children. Role of Branhamella catarrhalis. Drugs. 31:(Suppl. 3):1986;132-141.
9. Frosch P.W., Kolle. Die Mikrokokken, in Die Mikroorganism, Vol. 2. Flugge. 1896;154-155 Verlag von Vogel, Leipzig.
10. Enright M.C., McKenzie H. Moraxella (Branhamella) catarrhalis-clinical and molecular aspects of a rediscovered pathogen. J. Med. Microbiol. 46:1997;360-371.
11. Gordon J.E. The Gram-negative cocci in "colds" and influenza. J. Infect. Dis. 29:1921;462-494.
12. Catlin B.W., Reyn A. Neisseria gonorrhoeae isolated from disseminated and localised infections in pre-penicillin era. Auxotypes and antibacterial drug resistances. Br. J. Vener. Dis. 58:1982;158-165.
13. Bovre K. Proposal to divide the genus Moraxella into two subgenera, subgenus Moraxella and subgenus Branhamella. Int. J. Syst. Bacteriol. 29:1979;403-406.
14. Murphy T.F. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol. Rev. 60:1996;267-279.
15. Rossau R., Duhamel M., Jannes G., Decourt J.L., Van Heuverswyn H. The development of specific rRNA-derived oligonucleotide probes for Haemophilus ducreyi, the causative agent of chancroid. J. Gen. Microbiol. 137:1991;277-285.
16. Faden H., Bernstein J., Brodsky L., Stanievich J., Ogra P.L. Effect of prior antibiotic treatment on middle ear disease in children. Ann. Otol. Rhinol. Laryngol. 101:1992;87-91.
17. Faden H., Hong J., Murphy T. Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media. Infect. Immun. 60:1992;3824-3829.
18. Faden H., Waz M.J., Bernstein J.M., Brodsky L., Stanievich J., Ogra P.L. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann. Otol. Rhinol. Laryngol. 100:1991;612-615.
19. Gan V.N., Kusmiesz H., Shelton S., Nelson J.D. Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media. Antimicrob. Agents Chemother. 35:1991;967-971.
20. Ruuskanen O., Heikkinen T. Otitis media: etiology and diagnosis. Pediatr. Infect. Dis. J. 13:1994;23-26.
21. Klein J.O. Otitis media. Clin. Infect. Dis. 19:1994;823-833.
22. Stool S.E., Field M.J. The impact of otitis media. Pediatr. Infect. Dis. J. 8:1989;S11-S14.
23. Meyer G.A., Shope T.R., Waecker N.J. Jr, Lanningham F.M. Moraxella (Branhamella) catarrhalis bacteremia in children. A report of two patients and review of the literature. Clin. Pediatr. (Phila). 34:1995;146-150.
24. Klugman K.P. The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. J. Antimicrob. Chemother. 38:(Suppl. A):1996;133-140.
25. Daoud A. Neonatal meningitis due to Moraxella catarrhalis and review of the literature. Ann. Trop. Pediatr. 16:1996;199-201.
26. Chapman A.J. Jr, Musher D.M., Jonsson S., Clarridge J.E., Wallace R.J. Jr. Development of bactericidal antibody during Branhamella catarrhalis infection. J. Infect. Dis. 151:1985;878-882.
27. McLeod D.T., Ahmad F., Croughan M.J., Calder M.A. Bronchopulmonary infection due to B. catarrhalis. Clinical features and therapeutic response. Drugs. 31:(Suppl. 3):1986;109-112.
28. Murphy T.F., Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 146:1992;1067-1083.
29. Nicotra B., Rivera M., Luman J.I., Wallace R.J. Jr. Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch. Intern. M. 146:1986;890-893.
30. Doern G.V., Miller M.J., Winn R.E. Branhamella (Neisseria) catarrhalis systemic disease in humans. Case reports and review of the literature. Arch. Intern. M. 141:1981;1690-1692.
31. Haddad J., Le Faou A., Simeoni U., Messer J. Hospital-acquired bronchopulmonary infection in premature infants due to Branhamella catarrhalis. J. Hosp. Infect. 7:1986;301-302.
32. Ninane G., Joly J., Kraytman M. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture. Br. Med. J. 1:1978;276-278.
33. Wallace M.R., Oldfield E.C. Moraxella (Branhamella) catarrhalis bacteremia. A case report and literature review. Arch. Intern. M. 150:1990;1332-1334.
34. Wallace R.J. Jr, Nash D.R., Steingrube V.A. Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis. Am. J. M. 88:1990;46S-50S.
35. Patterson T.F., Patterson J.E., Masecar B.L., Barden G.E., Hierholzer W.J. Jr, Zervos M.J. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. J. Infect. Dis. 157:1988;996-1001.
36. Patterson J.E., Patterson T.F., Farrel P., Hierholzer W.J. Jr, Zervos M.J. Evaluation of restriction endonuclease analysis as an epidemiologic typing system for Branhamella catarrhalis. J. Clin. Microbiol. 27:1989;944-946.
37. McKenzie H., Morgan M.G., Jordens J.Z., Enright M.C., Bain M. Characterisation of hospital isolates of Moraxella (Branhamella) catarrhalis by SDS-PAGE of whole-cell proteins, immunoblotting and restriction-endonuclease analysis. J. Med. Microbiol. 37:1992;70-76.
38. Beaulieu D., Scriver S., Bergeron M.G., Low D.E., Parr T.R. Jr, Patterson J.E., Matlow A., Roy P.H. Epidemiological typing of Moraxella catarrhalis by using DNA probes. J. Clin. Microbiol. 31:1993;736-739.
39. Richards S.J., Greening A.P., Enright M.C., Morgan M.G., McKenzie H. Outbreak of Moraxella catarrhalis in a respiratory unit. Thorax. 48:1993;91-92.
40. Picard B., Goullet P., Denamur E., Suermondt G. Esterase electrophoresis: a molecular tool for studying the epidemiology of Branhamella catarrhalis nosocomial infection. Epidemiol. Infect. 103:1989;547-554.
41. Meeker D.P., Longworth D.L. Community-acquired pneumonia: an update. Cleve. Clin. J. M. 63:1996;16-30.
42. Brorson J.E., Axelsson A., Holm S.E. Studies on Branhamella catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scand. J. Infect. Dis. 8:1976;151-155.
43. Jousimies-Somer H.R., Savolainen S., Ylikoski J.S. Comparison of the nasal bacterial floras in two groups of healthy subjects and in patients with acute maxillary sinusitis. J. Clin. Microbiol. 27:1989;2736-2743.
44. Craig D.B., Wehrle P.A. Branhamella catarrhalis septic arthritis. J. Rheumatol. 10:1983;985-986.
45. Melendez P.R., Johnson R.H. Bacteremia and septic arthritis caused by Moraxella catarrhalis. Rev. Infect. Dis. 13:1991;428-429.
46. Cimolai N., Adderley R.J. Branhamella catarrhalis bacteremia in children. Acta Paediatr. Scand. 78:1989;465-468.
47. Ioannidis J.P., Worthington M., Griffiths J.K., Snydman D.R. Spectrum and significance of bacteremia due to Moraxella catarrhalis. Clin. Infect. Dis. 21:1995;390-397.
48. Rotta A.T., Asmar B.I. Moraxella catarrhalis bacteremia and preseptal cellulitis. South. Med. J. 87:1994;541-542.
49. Prallet B., Lucht F., Alexandre C. Vertebral osteomyelitis due to Branhamella catarrhalis [letter]. Rev. Infect. Dis. 13:1991;769.
50. Douer D., Danziger Y., Pinkhas J. Neisseria catarrhalis endocarditis [letter]. Ann. Intern. M. 86:1977;116.
51. Sanyal S.K., Wilson N., Twum-Danso K., Abomelha A., Sohel S. Moraxella endocarditis following balloon angioplasty of aortic coarctation. Am. Heart J. 119:1990;1421-1423.
52. Kostiala A.A., Honkanen T. Branhamella catarrhalis as a cause of acute purulent pericarditis [letter]. J. Infect. 19:1989;291-292.
53. Pollard J.A., Wallace R.J. Jr, Nash D.R., Luman J.I., Wilson R.W. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease. Drugs. 31:(Suppl. 3):1986;103-108.
54. Van Hare G.F., Shurin P.A., Marchant C.D., Cartelli N.A., Johnson C.E., Fulton D., Carlin S., Kim C.H. Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev. Infect. Dis. 9:1987;16-27.
55. Wright P.W., Wallace R.J. Jr, Shepherd J.R. A descriptive study of 42 cases of Branhamella catarrhalis pneumonia. Am. J. M. 88:1990;2S-8S.
56. Faden H., Harabuchi Y., Hong J.J. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media. J. Infect. Dis. 169:1994;1312-1317.
57. Aniansson G., Alm B., Andersson B., Larsson P., Nylen O., Peterson H., Rigner P., Svanborg M., Svanborg C. Nasopharyngeal colonization during the first year of life. J. Infect. Dis. 165:(Suppl. 1):1992;S38-S42.
58. Leach A.J., Boswell J.B., Asche V., Nienhuys T.G., Mathews J.D. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants. Pediatr. Infect. Dis. J. 13:1994;983-989.
59. Faden H., Duffy L., Wasielewski R., Wolf J., Krystofik D., Tung Y. Relationship between nasopharyngeal colonization and the development of otitis media in children. Tonawanda/Williamsville Pediatrics. J. Infect. Dis. 175:1997;1440-1445.
60. Vives M., Garcia M.E., Saenz P., Mora M.A., Mata L., Sabharwal H., Svanborg C. Nasopharyngeal colonization in Costa Rican children during the first year of life. Pediatr. Infect. Dis. J. 16:1997;852-958.
61. Zalacain R., Sobradillo V., Amilibia J., Barron J., Achotegui V., Pijoan J.I., Llorente J.L. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur. Respir. J. 13:1999;343-348.
62. Monso E., Ruiz J., Rosell A., Manterola J., Fiz J., Morera J., Ausina V. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am. J. Respir. Crit. Care M. 152:1995;1316-1320.
63. Klingman K.L., Pye A., Murphy T.F., Hill S.L. Dynamics of respiratory tract colonization by Branhamella catarrhalis in bronchiectasis. Am. J. Respir. Crit. Care M. 152:1995;1072-1078.
64. Harabuchi Y., Faden H., Yamanaka N., Duffy L., Wolf J., Krystofik D. Nasopharyngeal colonization with nontypeable Haemophilus influenzae and recurrent otitis media. Tonawanda/Williamsville Pediatrics. J. Infect. Dis. 170:1994;862-866.
65. Hoi-Dang A.B., Brive-Le Bouguenec C., Barthelemy M., Labia R. Novel beta-lactamase from Branhamella catarrhalis. Ann. Microbiol. (Paris). 129B:1978;397-406.
66. Felmingham D., Washington J. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens - findings of the Alexander Project 1992-1996. J. Chemother. 11:(Suppl. 1):1999;5-21.
67. Wallace R.J. Jr, Steingrube V.A., Nash D.R., Hollis D.G., Flanagan C., Brown B.A., Labidi A., Weaver R.E. BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens and M. lacunata. Antimicrob. Agents Chemother. 33:1989;1845-1854.
68. Bootsma H.J., Van Dijk H., Verhoef J., Fleer A., Mooi F.R. Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis. Antimicrob. Agents Chemother. 40:1996;966-972.
69. Fung C.P., Yeo S.F., Livermore D.M. Extraction of beta-lactamase from Moraxella catarrhalis [letter]. J. Antimicrob. Chemother. 34:1994;183-184.
70. Hol C., Van Dijke E.E., Verduin C.M., Verhoef J., Van Dijk H. Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia. J. Infect. Dis. 170:1994;1613-1616.
71. Brook I. Direct and indirect pathogenicity of Branhamella catarrhalis. Drugs. 31:(Suppl. 3):1986;97-102.
72. Kallings I. Sensitivity of Branhamella catarrhalis to oral antibiotics. Drugs. 31:(Suppl. 3):1986;17-22.
73. Davies B.I., Maesen F.P. Epidemiological and bacteriological findings on Branhamella catarrhalis respiratory infections in The Netherlands. Drugs. 31:(Suppl. 3):1986;28-33.
74. McLeod D.T., Ahmad F., Calder M.A. Infection and Branhamella catarrhalis. Biomed. Pharmacother. 39:1985;170-173.
75. Wardle J.K. Branhamella catarrhalis as an indirect pathogen. Drugs. 31:(Suppl. 3):1986;93-96.
76. Doern G.V. Resistance among problem respiratory pathogens in pediatrics. Pediatr. Infect. Dis. J. 14:1995;420-423.
77. Murphy T.F., Bartos L.C. Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis. Infect. Immun. 57:1989;2938-2941.
78. Helminen M.E., MacIver I., Latimer J.L., Cope L.D., McCracken G.H. Jr, Hansen E.J. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect. Immun. 61:1993;2003-2010.
79. Campagnari A.A., Shanks K.L., Dyer D.W. Growth of Moraxella catarrhalis with human transferrin and lactoferrin: expression of iron-repressible proteins without siderophore production. Infect. Immun. 62:1994;4909-4914.
80. Aebi C., Stone B., Beucher M., Cope L.D., Maciver I., Thomas S.E., McCracken G.H. Jr, Sparling P.F., Hansen E.J. Expression of the CopB outer membrane protein by Moraxella catarrhalis is regulated by iron and affects iron acquisition from transferrin and lactoferrin. Infect. Immun. 64:1996;2024-2030.
81. Bonnah R.A., Yu R.H., Wong H., Schryvers A.B. Biochemical and immunological properties of lactoferrin binding proteins from Moraxella (Branhamella) catarrhalis. Microb. Pathog. 24:1998;89-100.
82. Schryvers A.B., Bonnah R., Yu R.H., Wong H., Retzer M. Bacterial lactoferrin receptors. Adv. Exp. Med. Biol. 443:1998;123-133.
83. Sethi S., Hill S.L., Murphy T.F. Serum antibodies to outer membrane proteins (OMPs) of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: identification of OMP B1 as an important antigen. Infect. Immun. 63:1995;1516-1520.
84. Murphy T.F., Kirkham C., Lesse A.J. The major heat-modifiable outer membrane protein CD is highly conserved among strains of Branhamella catarrhalis. Mol. Microbiol. 10:1993;87-97.
85. Hsiao C.B., Sethi S., Murphy T.F. Outer membrane protein CD of Branhamella catarrhalis: sequence conservation in strains recovered from the human respiratory tract. Microb. Pathog. 19:1995;215-225.
86. Yang Y.P., Myers L.E., McGuinness U., Chong P., Kwok Y., Klein M.H., Harkness R.E. The major outer membrane protein, CD, extracted from Moraxella (Branhamella) catarrhalis is a potential vaccine antigen that induces bactericidal antibodies. FEMS Immunol. Med. Microbiol. 17:1997;187-199.
87. Murphy T.F., Kyd J.M., John A., Kirkham C., Cripps A.W. Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model. J. Infect. Dis. 178:1998;1667-1675.
88. Murphy T.F., Kirkham C., Denardin E., Sethi S. Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis. Infect. Immun. 67:1999;4578-4585.
89. Aebi C., Maciver I., Latimer J.L., Cope L.D., Stevens M.K., Thomas S.E., McCracken G.H. Jr, Hansen E.J. A protective epitope of Moraxella catarrhalis is encoded by two different genes. Infect. Immun. 65:1997;4367-4377.
90. Cope L.D., Lafontaine E.R., Slaughter C.A., Hasemann C.A. Jr, Aebi C., Henderson F.W., McCracken G.H. Jr, Hansen E.J. Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products. J. Bacteriol. 181:1999;4026-4034.
91. Klingman K.L., Murphy T.F. Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis. Infect. Immun. 62:1994;1150-1155.
92. Aebi C., Lafontaine E.R., Cope L.D., Latimer J.L., Lumbley S.L., McCracken G.H. Jr, Hansen E.J. Phenotypic effect of isogenic uspA1 and uspA2 mutations on Moraxella catarrhalis 035E. Infect. Immun. 66:1998;3113-3119.
93. McMichael J.C., Fiske M.J., Fredenburg R.A., Chakravarti D.N., Vandermeid K.R., Barniak V., Caplan J., Bortell E., Baker S., Arumugham R., Chen D. Isolation and characterization of two proteins from Moraxella catarrhalis that bear a common epitope. Infect. Immun. 66:1998;4374-4381.
94. Chen D., Barniak V., Vandermeid K.R., McMichael J.C. The levels and bactericidal capacity of antibodies directed against the UspA1 and UspA2 outer membrane proteins of Moraxella (Branhamella) catarrhalis in adults and children. Infect. Immun. 67:1999;1310-1316.
95. Helminen M.E., Maciver I., Latimer J.L., Klesney-Tait J., Cope L.D., Paris M., McCracken G.H. Jr, Hansen E.J. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J. Infect. Dis. 170:1994;867-872.
96. Bhushan R., Craigie R., Murphy T.F. Molecular cloning and characterization of outer membrane protein E of Moraxella (Branhamella) catarrhalis. J. Bacteriol. 176:1994;6636-6643.
97. Bhushan R., Kirkham C., Sethi S., Murphy T.F. Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis. Infect. Immun. 65:1997;2668-2675.
98. Ahmed K., Rikitomi N., Nagatake T., Matsumoto K. Electron microscopic observation of Branhamella catarrhalis. Microbiol. Immunol. 34:1990;967-975.
99. Marrs C.F., Weir S. Pili (fimbriae) of Branhamella species. Am. J. M. 88:1990;36S-40S.
100. Schryvers A.B. Identification of the transferrin- and lactoferrin-binding proteins in Haemophilus influenzae. J. Med. Microbiol. 29:1989;121-130.
101. Campagnari A.A., Ducey T.F., Rebmann C.A. Outer membrane protein B1, an iron-repressible protein conserved in the outer membrane of Moraxella (Branhamella) catarrhalis, binds human transferrin. Infect. Immun. 64:1996;3920-3924.
102. Luke N.R., Russo T.A., Luther N., Campagnari A.A. Use of an isogenic mutant constructed in Moraxella catarrhalis to identify a protective epitope of outer membrane protein B1 defined by monoclonal antibody 11C6. Infect. Immun. 67:1999;681-687.
103. Bonnah R.A., Yu R., Schryvers A.B. Biochemical analysis of lactoferrin receptors in the Neisseriaceae: identification of a second bacterial lactoferrin receptor protein. Microb. Pathog. 19:1995;285-297.
104. Cornelissen C.N., Sparling P.F. Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens. Mol. Microbiol. 14:1994;843-850.
105. Gray-Owen S.D., Schryvers A.B. Bacterial transferrin and lactoferrin receptors. Trends Microbiol. 4:1996;185-191.
106. Schryvers A.B. Characterization of the human transferrin and lactoferrin receptors in Haemophilus influenzae. Mol. Microbiol. 2:1988;467-472.
107. Schryvers A.B., Lee B.C. Comparative analysis of the transferrin and lactoferrin binding proteins in the family Neisseriaceae. Can. J. Microbiol. 35:1989;409-415.
108. Yu R.H., Schryvers A.B. The interaction between human transferrin and transferrin binding protein 2 from Moraxella (Branhamella) catarrhalis differs from that of other human pathogens. Microb. Pathog. 15:1993;433-445.
109. Litwin C.M., Calderwood S.B. Role of iron regulation of virulence genes. Clin. Micro. Rev. 6:1993;137-149.
110. Luke N.R., Campagnari A.A. Construction and characterization of Moraxella catarrhalis mutants defective in expression of transferrin receptors. Infect. Immun. 67:1999.
111. Myers L.E, Yang Y.P, Du R.P, Wang Q, Harkness R.E, Schryvers A.B, Klein M.H, Loosmore S.M. The transferrin binding protein B ofMoraxella catarrhaliselicits bactericidal antibodies and is a potential vaccine antigen. Infect. Immun. 66:1998;4183-4192.
112. Du R.P., Wang Q., Yang Y.P., Schryvers A.B., Chong P., Klein M.H., Loosmore S.M. Cloning and expression of the Moraxella catarrhalis lactoferrin receptor genes. Infect. Immun. 66:1998;3656-3665.
113. Bonnah R.A., Wong H., Loosmore S.M., Schryvers A.B. Characterization of Moraxella (Branhamella) catarrhalis lbpB, lbpA, and lactoferrin receptor orf3 isogenic mutants. Infect. Immun. 67:1999;1517-1520.
114. Yu R., Bonnah R.A., Ainsworth S., Schryvers A.B. Analysis of the immunological responses to transferrin and lactoferrin receptor proteins from Moraxella catarrhalis. Infect. Immun. 67:1999;3793-3799.
115. Edebrink P., Jansson P.E., Rahman M.M., Widmalm G., Holme T., Rahman M., Weintraub A. Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr. Res. 257:1994;269-284.
116. Masoud H., Perry M.B., Richards J.C. Characterization of the lipopolysaccharide of Moraxella catarrhalis. Eur. J. Biochem. 220:1994;209-216.
117. Rahman M., Holme T. Antibody response in rabbits to serotype-specific determinants in lipopolysaccharides from Moraxella catarrhalis. J. Med. Microbiol. 44:1996;348-354.
118. Porat N., Apicella M.A., Blake M.S. A lipooligosaccharide-binding site on HepG2 cells similar to the gonococcal opacity-associated surface protein Opa. Infect. Immun. 63:1995;2164-2172.
119. Porat N., Apicella M.A., Blake M.S. Neisseria gonorrhoeae utilizes and enhances the biosynthesis of the asialoglycoprotein receptor expressed on the surface of the hepatic HepG2 cell line. Infect. Immun. 63:1995;1498-1506.
120. Apicella M.A., Mandrell R.E. Molecular mimicry as a factor in the pathogenesis of human Neisserial infections: in vitro and in vivo modification of the lipooligosaccharide of Neisseria gonorrhoeae by N-acetylneuraminic acid. Pediatr. Infect. Dis. J. 8:1989;901-902.
121. Edebrink P., Jansson P.E., Widmalm G., Holme T., Rahman M. The structures of oligosaccharides isolated from the lipopolysaccharide of Moraxella catarrhalis serotype B, strain CCUG 3292. Carbohydr. Res. 295:1996;127-146.
122. Mandrell R.E., Griffiss J.M., Macher B.A. Lipooligosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens. J. Exp. M. 168:1988;107-126.
123. Edebrink P., Jansson P.E., Rahman M.M., Widmalm G., Holme T., Rahman M. Structural studies of the O-antigen oligosaccharides from two strains of Moraxella catarrhalis serotype C. Carbohydr. Res. 266:1995;237-261.
124. Rahman M., Holme T., Jonsson I., Krook A. Lack of serotype-specific antibody response to lipopolysaccharide antigens of Moraxella catarrhalis during lower respiratory tract infection. Eur. J. Clin. Microbiol. Infect. Dis. 14:1995;297-304.
125. Gu X.X., Chen J., Barenkamp S.J., Robbins J.B., Tsai C.M., Lim D.J., Battey J. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis. Infect. Immun. 66:1998;1891-1897.
126. Unhanand M., Maciver I., Ramilo O., Arencibia-Mireles O., Argyle J.C., McCracken G.H. Jr, Hansen E.J. Pulmonary clearance of Moraxella catarrhalis in an animal model. J. Infect. Dis. 165:1992;644-650.
127. Kyd J.M., Cripps A.W., Murphy T.F. Outer-membrane antigen expression by Moraxella (Branhamella) catarrhalis influences pulmonary clearance. J. Med. Microbiol. 47:1998;159-168.
128. MacIver I., Unhanand M., McCracken G.H. Jr, Hansen E.J. Effect of immunization of pulmonary clearance of Moraxella catarrhalis in an animal model. J. Infect. Dis. 168:1993;469-472.
129. Harkness R.E., Guimond M.J., McBey B.A., Klein M.H., Percy D.H., Croy B.A. Branhamella catarrhalis pathogenesis in SCID and SCID/beige mice. Brief report. APMIS. 101:1993;805-810.
130. Giebink G.S., Ikberzins S.C. Marker, Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect. Immun. 30:1980;445-450.
131. Barenkamp S.J. Protection by serum antibodies in experimental nontypable Haemophilus influenzae otitis media. Infect. Immun. 52:1986;572-578.
132. Fulghum R.S., Marrow H.G. Experimental otitis media with Moraxella (Branhamella) catarrhalis. Ann. Otol. Rhinol. Laryngol. 105:1996;234-241.
133. Westman E.B., Ahermansson K., Prellner A., Melhus S., Hellstrom. Moraxella catarrhalis-induced purulent otitis media in the rat middle ear. Mogi G, Honig I, Ishii T, Takasaka T. Proceedings of the Second Extraordinary International Symposium on Recent Advances in Otitis Media. 1994;193-195 Kugler Publications, Amsterdam.
134. Doyle W.J. Animal models of otitis media: other pathogens. Pediatr. Infect. Dis. J. 8:1989;S45-S47.
135. Chung M.H., Enrique R., Lim D.J., Demaria T.F. Moraxella (Branhamella) catarrhalis-induced experimental otitis media in the chinchilla. Infect. Immun. 63:1994;4188-4190.
136. Suzuki K., Bakaletz L.O. Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media. Infect. Immun. 63:1994;4188-4190.
137. Bakaletz L.O., Murwin D.M., Billy J.M. Adenovirus serotype 1 does not act synergistically with Moraxella (Branhamella) catarrhalis to induce otitis media in the chinchilla. Infect. Immun. 63:1995;4188-4190.
138. Casselbrant M.L., Mandel E.M., Kurs-Lasky M., Rockette H.E., Bluestone C.D. Otitis media in a population of black American and white American infants, 0-2 years of age. Int. J. Pediatr. Otorhinolaryngol. 33:1995;1-16.
139. Pichichero M.E., Pichichero C.L. Persistent acute otitis media: I. Causative pathogens. Pediatr. Infect. Dis. J. 14:1995;178-183.
140. Rodriguez W.J., Schwartz R.H., Thorne M.M. Increasing incidence of penicillin- and ampicillin-resistant middle ear pathogens. Pediatr. Infect. Dis. J. 14:1995;1075-1078.
141. Gooch W.M.R., Blair E., Puopolo A., Paster R.Z., Schwartz R.H., Miller H.C., Smyre H.L., Yetman R., Giguere G.G., Collins J.J. Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media. Pediatr. Infect. Dis. J. 15:1996;157-164.
142. Watson P., Voss L., Barber C., Aickin R., Bremner D., Lennon D. The microbiology of chronic otitis media with effusion in a group of Auckland children. NZ Med. J. 109:1996;182-184.
143. Brook I., Gober A.E. Microbiologic characteristics of persistent otitis media. Arch. Otolaryngol. Head Neck Surg. 124:1998;1350-1352.